InvestoGain Australia

SEARCH LISTED COMPANY

ANY AUS OR NZ COMPANY

BROWSE

Browse Australian listed companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

BROWSE

Browse Australian listed companies

0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Browse Australian delisted companies/archived funds or use SEARCH

SEARCH PRIVATE COMPANY

SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

MICROBA LIFE SCIENCES LIMITED(MAP)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

 

Shareholder links

Our website ranking of MAP: rating 3
(3 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Level 5, 126 Philip Street Sydney NSW 2000 GPO Box 5193 Sydney NSW 2001

Tel : 1300 288 664 or +61 2 9698 5414
Fax : +61 2 8583 3040
RegistryWebsite RegistryEmail

Company details

ISIN: AU0000209868
Address: Level 10, 324 Queen Street, BRISBANE, QLD, AUSTRALIA, 4000
Tel:  +61 1300 974 621 Fax: +61 1300 974 621

Date first listed: 05/04/2022
Company Secretary: 
Sector:  Industry Group: 
Activities: Microba is a commercial stage company with leading technology for measuring the human gut microbiome

News & Events

Expand this box to read and print

The suspension of trading in the securities of Microba Life Sciences Limited will be lifted immediately following the release by MAP of an announcement regarding a capital raising.

23/06/2025

The company releases its Strategic Investment & Equity Raise Presentation.

23/06/2025

The company secured $14.5m to expand clinical adoption of microbiome testing, signed a new UK laboratory agreement, and updated revenue guidance. The funding will be used to drive clinical adoption of the company's core microbiome testing products. The company also signed a Commercial Laboratory Processing Agreement with The Doctors Laboratory.

23/06/2025

The company's securities will be suspended from quotation under Listing Rule 17.2 pending an announcement from MAP. The suspension will continue until the end of the requested period or announcement's release.

23/06/2025

listed entity carried for record purposes only

05/04/2022

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    Posting your comments. Please wait...

     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    17/09/2025Richard Bund-690,290$0.082$56,673.00
    10/09/2025Richard Bund-1,829,460$0.086$156,541.00
    19/11/2024Pasquale Rombola200,000$0.171$34,253.00
    14/11/2024Ian Frazer200,000$0.168$33,540.00
    30/10/2023Pasquale Rombola570,000$0.226$128,830.00

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Ian FrazerDeputy Chairman05/04/2022
    Luke ReidCEO05/04/2022
    James HeathCFO, Company Secretary05/04/2022
    Hyungtae KimNon Exec Director14/06/2019
    Gene TysonNon Exec Director05/04/2022
    Jacqueline FernleyNon Exec Director08/09/2022
    Richard BundNon Exec Director08/02/2018
    Pasquale RombolaDirector23/06/2017

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION

    Date of first appointment, title may have changed.